Ligand Pharmaceuticals's chart data is dated 2026-10-09. Recorded technical signals: MA aligned. There are 2 published signal records.
Ligand Pharmaceuticals last closed at $301.81 (+2.31%) on 2026-10-09. Signals today: MA aligned. Listed on Nasdaq. Trailing 12 months PER is 33.4×. Its overall grade ranks 69 of 736 stocks in Healthcare.
About this company
Ligand Pharmaceuticals last closed at $301.81 (+2.31%) on 2026-10-09. Signals today: MA aligned. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A+ · 69/736
Valuation grade F
Related stocks
- AmgenCustomer
Ligand의 로열티·라이선스 수취와 연결된 주요 제약 고객
- Merck & Co.Customer
주요 파트너/라이선스 수익 관련 대형 제약사
- Bristol Myers SquibbCustomer
Ligand의 플랫폼 및 로열티 기반 수익과 연결된 대형 고객사
ETFs holding this stock
Franklin Genomic Advancements ETF · Invesco S&P SmallCap Health Care ETF · Invesco S and P SmallCap Momentum ETF
Details →About Ligand Pharmaceuticals
- What technical signals does Ligand Pharmaceuticals (LGND) have?
- Ligand Pharmaceuticals current technical signals: MA alignment (score 0.45).
- Is Ligand Pharmaceuticals a cup-and-handle pattern?
- No. Ligand Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Ligand Pharmaceuticals?
- Market cap: $5.94B. Trailing 12 months PER: 33.4×. Latest quarter PBR: 6.81×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-10 dataset
Turn what you saw on this name into a strategy
Ask Q about Ligand Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.